Inactivated poliovirus vaccine in reduced doses

also known as fIPV · fractionated IPV · IPV

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Comparator or background therapy1 trial
Phase 2	NCT04027036 Comparator	Aug 2020 → May 2022	poliomyelitis	Instituto Nacional de Saúde, Mozambique	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Inactivated poliovirus vaccine in reduced doses	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04027036 ↗
Known as	fIPV	“Administration of fractionated IPV (fIPV), i.e., 1/5 (0.1mL) of the standard dose, intradermally has shown to be safe” NCT04027036 ↗
Known as	fractionated IPV	“Administration of fractionated IPV (fIPV), i.e., 1/5 (0.1mL) of the standard dose, intradermally has shown to be safe” NCT04027036 ↗
Known as	IPV	“The oral vaccine (OPV) is administered at months 0,2,3, and 4 and a single dose of the inactivated poliovirus vaccine (IPV) is given intramuscularly at month 4.” NCT04027036 ↗
Modality	Vaccine	“The fractional IPV vaccine will be given to children at 2 and 4 months of age during routine vaccinations.” NCT04027036 ↗
Route	Intramuscular	“receive 0,1 ml of inactivated poliovirus vaccine intramuscularly” NCT04027036 ↗